Tenaya Therapeutics, Inc. (TNYA)
0.89
+0.04
(+4.90%)
USD |
NASDAQ |
May 08, 10:44
Tenaya Therapeutics Research and Development Expense (Annual) : 68.61M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Marker Therapeutics, Inc. | 11.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Vericel Corp. | 27.56M |
| Anavex Life Sciences Corp. | 37.59M |
| Protagonist Therapeutics, Inc. | 159.29M |